Servicio de Cardiología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain.
Servicio de Cardiología, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Rev Esp Cardiol (Engl Ed). 2021 Nov;74(11):962-970. doi: 10.1016/j.rec.2021.08.001. Epub 2021 Sep 9.
The present report updates the main characteristics and outcomes of heart transplants in Spain to 2020.
We describe the main features of recipients, donors, surgical procedure, and immunosuppression in 2020. We also analyze the temporal trends of these characteristics and outcomes (survival) for the period 2011 to 2019.
In 2020, 278 heart transplants were performed (7.3% decrease vs 2019). The findings in 2020 confirmed previous observations of an increase in pretransplant sternotomy, a slight decrease in urgent transplants carried out with ventricular assist devices, a slight decrease in donor age, an increase in the use of allografts with previous arrest, and a decrease in ischemia time. Survival continued to improve in recent triennia, reaching 82.0% at 1 year in the period 2017 to 2019.
The slight decrease in the number of heart transplants performed in 2020 in Spain, most likely due to the SARS-CoV-2 pandemic, did not change the main characteristics of the procedure. No change was observed in the tendency to improved survival.
本报告更新了截至 2020 年西班牙心脏移植的主要特征和结果。
我们描述了 2020 年受者、供者、手术程序和免疫抑制的主要特征。我们还分析了 2011 年至 2019 年期间这些特征和结果(存活率)的时间趋势。
2020 年进行了 278 例心脏移植(比 2019 年减少 7.3%)。2020 年的结果证实了之前观察到的移植前胸骨切开术增加、使用心室辅助装置进行紧急移植的情况略有减少、供体年龄略有下降、以前停搏的同种异体移植物的使用增加以及缺血时间减少。在最近的三年中,存活率继续提高,在 2017 年至 2019 年期间,1 年的存活率达到 82.0%。
西班牙 2020 年心脏移植数量略有下降,可能是由于 SARS-CoV-2 大流行所致,但手术的主要特征并未改变。存活率的改善趋势没有变化。